A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kiran Patel, MD
Upstream Bio
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Nzz Mudr Pavel Navratil
Olomouc, Czech Republic, Czechia
- Charite Universitaetsmedizin Berlin
Berlin, Germany
- Universitaetsklinik Muenster, Klinik Fur Hals-, Nasen- Und Ohrenheilkunde
Münster, Germany
- Universitätsklinik Tuebingen
Tübingen, Germany
- Centrum Medyczne Angelius Provita
Katowice, Poland
- Centrum Medyczne "all-Med" Badania Kliniczne Spolka Komandytowa
Krakow, Poland
- Centrum Medyczne Promed
Krakow, Poland
- Centrum Słuchu I Mowy Sp. Z O.O.
Nadarzyn, Poland
- Centrum Medyczne Lucyna Andrzej Dymek S.C
Strzelce Opolskie, Poland
- Centro Médico Teknon
Barcelona, Spain
- Hospital Universitario de Jerez de la Frontera
Cadiz, Spain
- Hospital Universitario Fundacion Jimenez Diaz (uam-Fjd) Consultas Externas Isaac Peral
Madrid, Spain
- Hospital Universitario Ramón Y Cajal
Madrid, Spain
- Hospital Universitario Virgen Macarena
Seville, Spain
- Sensa Health la (sensa Health Clinical Research)
Los Angeles, California, United States
- Newportnativemd, Inc.
Newport Beach, California, United States
- Davinci, Research Llc
Roseville, California, United States
- Senta Clinic
San Diego, California, United States
- University of Missouri
Columbus, Colorado, United States
- Western States Clinical Research, Inc.
Wheat Ridge, Colorado, United States
- Alfa Medical Research
Hollywood, Florida, United States
- Imic Inc.
Miami, Florida, United States
- Novaceut Clinical Research
Miami, Florida, United States
- Well Pharma Medical Research Corp.
Miami, Florida, United States
- University of South Florida
Tampa, Florida, United States
- Treasure Valley Medical Research
Boise, Idaho, United States
- the University of Chicago
Chicago, Illinois, United States
- Advanced Ent and Allergy
Louisville, Kentucky, United States
- Chesapeake Clinical Research, Inc.
White Marsh, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Northwell Health/division of Allergy and Immunology
Great Neck, New York, United States
- University of Cincinnati Medical Center
Cincinnati, Ohio, United States
- Allergy, Asthma & Clinical Research Center
Oklahoma City, Oklahoma, United States
- Spartanburg /greer Ent & Allergy
Spartanburg, South Carolina, United States
- Orion Clinical Research
Austin, Texas, United States
- Alina Clinical Trials, Llc.
Dallas, Texas, United States
- Ears Nose and Throat Associates of Texas
McKinney, Texas, United States
- Alamo Ent Associates
San Antonio, Texas, United States
- Eastern Virginia Medical School
Norfolk, Virginia, United States
- Bellingham Asthma, Allergy & Immunology Clinic
Bellingham, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Dec 2023
- Primary completion
- 7 Jul 2025
- Completion
- 22 Jul 2025
- Last update posted
- 15 Aug 2025
- Registered enrollment
- 81
- Registry id
- NCT06164704
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.